Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QV3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,721
Award facts
- Contract value 100% obligated
- $14,720.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 16, 2026, valued at $14,720.89 for the supply of Jardiance 10 mg tablets (90-count packages) to the Defense Logistics Agency. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 20, 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide.
Amerisourcebergen Drug Corp's position as a prime vendor for federal pharmaceutical procurement reflects its capability to compete successfully for medical supply contracts across multiple therapeutic domains. The DLA Medical Supply Chain relies on pharmaceutical distributors such as Amerisourcebergen to ensure consistent availability of critical medications, including diabetes treatments like Jardiance, to support military treatment facilities and veteran healthcare systems. The company's established IDC framework with DLA allows for efficient fulfillment of routine pharmaceutical replenishment orders through delivery orders, streamlining the procurement process for essential government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5QV3?
SPE2DR26F5QV3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F5QV3 worth?
The government has obligated $14,721 on SPE2DR26F5QV3.
Is contract SPE2DR26F5QV3 an order under another contract?
Yes. SPE2DR26F5QV3 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QV3 competed?
The extent of competition for SPE2DR26F5QV3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award